Infusive Asset Management Inc. grew its position in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 56.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 77,601 shares of the company's stock after purchasing an additional 28,055 shares during the period. Procter & Gamble makes up approximately 4.8% of Infusive Asset Management Inc.'s holdings, making the stock its 6th biggest position. Infusive Asset Management Inc.'s holdings in Procter & Gamble were worth $11,121,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC lifted its stake in shares of Procter & Gamble by 51.5% in the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company's stock worth $6,717,000 after acquiring an additional 13,617 shares during the period. Taylor Financial Group Inc. lifted its stake in shares of Procter & Gamble by 10.6% in the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company's stock worth $493,000 after acquiring an additional 277 shares during the period. Sivia Capital Partners LLC lifted its stake in shares of Procter & Gamble by 19.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company's stock worth $979,000 after acquiring an additional 1,016 shares during the period. Auxano Advisors LLC lifted its stake in shares of Procter & Gamble by 10.8% in the 2nd quarter. Auxano Advisors LLC now owns 7,315 shares of the company's stock worth $1,165,000 after acquiring an additional 714 shares during the period. Finally, Schnieders Capital Management LLC. lifted its stake in shares of Procter & Gamble by 2.8% in the 2nd quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company's stock worth $4,809,000 after acquiring an additional 809 shares during the period. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Stock Up 0.8%
PG stock opened at $149.47 on Friday. Procter & Gamble Company has a 12 month low of $137.62 and a 12 month high of $167.25. The firm has a market cap of $348.04 billion, a PE ratio of 21.85, a P/E/G ratio of 6.51 and a beta of 0.39. The firm has a 50 day simple moving average of $144.63 and a 200 day simple moving average of $147.70. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.73 and a quick ratio of 0.53.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Friday, April 24th. The company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.56 by $0.03. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The business had revenue of $21.24 billion during the quarter, compared to analyst estimates of $21.52 billion. During the same period in the prior year, the business earned $1.54 earnings per share. The business's quarterly revenue was up 7.4% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities research analysts forecast that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Friday, April 24th were given a $1.0885 dividend. This is a boost from Procter & Gamble's previous quarterly dividend of $1.06. The ex-dividend date was Friday, April 24th. This represents a $4.35 annualized dividend and a dividend yield of 2.9%. Procter & Gamble's payout ratio is currently 63.60%.
Analyst Ratings Changes
A number of brokerages have recently weighed in on PG. Rothschild & Co Redburn reduced their price target on shares of Procter & Gamble from $157.00 to $155.00 and set a "neutral" rating for the company in a research note on Monday, April 27th. The Goldman Sachs Group reduced their price target on shares of Procter & Gamble from $159.00 to $155.00 and set a "neutral" rating for the company in a research note on Wednesday, April 8th. Wells Fargo & Company increased their target price on shares of Procter & Gamble from $158.00 to $164.00 and gave the company an "overweight" rating in a research note on Monday, April 27th. UBS Group increased their target price on shares of Procter & Gamble from $166.00 to $172.00 and gave the company a "buy" rating in a research note on Monday, April 27th. Finally, JPMorgan Chase & Co. cut their target price on shares of Procter & Gamble from $165.00 to $162.00 and set an "overweight" rating for the company in a research note on Friday, April 17th. Eleven analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $160.78.
Read Our Latest Report on Procter & Gamble
About Procter & Gamble
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Read More
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.